"Stanoven\u00ED prevalence GBV-c/HGV infekce u HIV pozitivn\u00EDch pacient\u016F a zji\u0161\u0165ov\u00E1n\u00ED mo\u017En\u00E9ho vlivu GBV-c/HGV na pr\u016Fb\u011Bh infekce HIV stanoven\u00EDm imulogick\u00FDch a virologick\u00FDch marker\u016F progrese HIV infekce. METODIKA: V roce 2002 a 2003 jsme vy\u0161et\u0159ili s\u00E9ra u 273 HIV pozitivn\u00EDch pacient\u016F z AIDS-centra FN Bulovka Praha na p\u0159\u00EDtomnost marker\u016F GBV-c/HGV infekce semikvantitativn\u00EDm stanoven\u00EDm HGV PCR a anti-E2 protil\u00E1tek metodou ELISA. 271 s\u00E9rov\u00FDch vzork\u016F bylo vy\u0161et\u0159eno na HGV PCR a 269 vzork\u016F na antiE2.V den odb\u011Bru byla zji\u0161\u0165ov\u00E1na HIV vir\u00E9mie a po\u010Det CD4 lymfocyt\u016F. Z\u00E1vislost po\u010Dtu CD4 lymfocyt\u016F a virov\u00E9 n\u00E1lo\u017Ee HIV na infekci virem HGV jsme zji\u0161\u0165ovali Spearmanov\u00FDm testem. V\u00DDSLEDKY: 89 (33,3%) pacient\u016F m\u011Blo pozitivn\u00ED PCR HGV a 101 (38,5%) pacient\u016F m\u011Blo pozitivn\u00ED test anti-E2 metodou ELISA. Statisticky v\u00FDznamn\u00FD vliv GBV-c/HGV infekce u HIV infikovan\u00FDch na po\u010Det CD4 lymfocyt\u016F a na virovou n\u00E1lo\u017E HIV nebyl v na\u0161em souboru prok\u00E1z\u00E1n. Z\u00C1V\u011AR: Na\u0161e sledov\u00E1n\u00ED nepotvrzuje vliv GBV-c/HGV infekce na z\u00E1kladni prediktivn\u00ED laboratorn\u00ED"@cs . . . . . "Prevalence of GBV-c/HGV in HIV-infected patients and potential influence of coinfection on the course of the disease./Prevalence GBV-c/HGV u HIV infikovan\u00FDch pacient\u016F a možn\u00FD v\u00FDznam koinfekce pro v\u00FDvoj nemoci"@cs . "Objectives: Assessment of prevalence of GBV-c/HGV infection in HIV-infected patients and evaluating of a possible influence of GBV-c/HGV on the course of HIV infection by assessment of immunological and virological markers of progression of HIV infection. Methods: We have investigated seras of 273 HIV-infected patients from AIDS Center of the University Hospital Na Bulovce Prague during 2002-2003. Our target was to assess the presence of markers of GBV-c/HGV infection by semiquantitative HGV PCR evaluation and anti-E2 antibodies by ELISA testing. 271 of serum samples were tested for HGV PCR and 269 samples were tested for anti-E2 antibodies. HIV viral load and CD4 count were tested concurrently. We used Spearman\u00B4s test to rule out the dependency of CD4 count and HIV viral load on HGV infection. Results: 89 (33,3%) of patients were positive in PCR HGV test and 101 (38,5%) of patients were positive in anti E2-ELISA. No statistically significant efect of GBV-c/HGV infection was observed on CD4 count an"@en . "Prevalence of GBV-c/HGV in HIV-infected patients and potential influence of coinfection on the course of the disease."@en . "5"^^ . . . "Prevalence of GBV-c/HGV in HIV-infected patients and potential influence of coinfection on the course of the disease." . "1"^^ . . . . . . . . . . . . "4"^^ . "prevalence;GBV/c/HGV;HIV;infected;patients;influence;coinfection;course;disease;immunological;virological;markers;progression;infection;273;infected;patients;AIDS;Center;Prague;viral;load;CD4;dependency;HGV PCR;33%;positive;anti-E2;38,5%;effect;predictiv"@en . . "Prevalence of GBV-c/HGV in HIV-infected patients and potential influence of coinfection on the course of the disease." . "1198-743X" . . "Aster, Viktor" . "[4971C08A7426]" . "157-157" . . "Objectives: Assessment of prevalence of GBV-c/HGV infection in HIV-infected patients and evaluating of a possible influence of GBV-c/HGV on the course of HIV infection by assessment of immunological and virological markers of progression of HIV infection. Methods: We have investigated seras of 273 HIV-infected patients from AIDS Center of the University Hospital Na Bulovce Prague during 2002-2003. Our target was to assess the presence of markers of GBV-c/HGV infection by semiquantitative HGV PCR evaluation and anti-E2 antibodies by ELISA testing. 271 of serum samples were tested for HGV PCR and 269 samples were tested for anti-E2 antibodies. HIV viral load and CD4 count were tested concurrently. We used Spearman\u00B4s test to rule out the dependency of CD4 count and HIV viral load on HGV infection. Results: 89 (33,3%) of patients were positive in PCR HGV test and 101 (38,5%) of patients were positive in anti E2-ELISA. No statistically significant efect of GBV-c/HGV infection was observed on CD4 count an" . "P(NI7509)" . "RIV/00064211:_____/04:00011348!RIV/2005/MZ0/L10005/N" . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . . "K\u00F6nig, Jaroslav" . "Prevalence of GBV-c/HGV in HIV-infected patients and potential influence of coinfection on the course of the disease."@en . "suppl.3" . . . . . "RIV/00064211:_____/04:00011348" . . . . . "Sta\u0148kov\u00E1, Marie" . . . . . . "10" . "Clinical Microbiology and Infection" . . . "Prevalence of GBV-c/HGV in HIV-infected patients and potential influence of coinfection on the course of the disease./Prevalence GBV-c/HGV u HIV infikovan\u00FDch pacient\u016F a možn\u00FD v\u00FDznam koinfekce pro v\u00FDvoj nemoci"@cs . . . . . . "Proch\u00E1zka, Bohumil" . . "581651" . "Rozsypal, Hanu\u0161" . .